SCHEMBL7622583

SCHEMBL7622583

CCC(=O)c1cccc(S(=O)(=O)NC(=O)Nc2c(C(C)C)cccc2C(C)C)c1.CCC(=O)c1cccc(S(N)(=O)=O)c1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141521 0.95 NLRP3 (0.69) NLRP3
SCHEMBL7612300 0.92 NLRP3 (0.66) NLRP3
SCHEMBL7616971 0.88 NLRP3 (0.66) NLRP3
SCHEMBL7140501 0.88 NLRP3 (0.75) NLRP3
SCHEMBL7137322 0.86 NLRP3 (0.72) NLRP3
SCHEMBL7613078 0.85 NLRP3 (0.56) NLRP3
SCHEMBL7611971 0.84 NLRP3 (0.61) NLRP3
SCHEMBL7611975 0.84 NLRP3 (0.61) NLRP3
SCHEMBL7611930 0.84 NLRP3 (0.74) NLRP3
SCHEMBL7614942 0.84 NLRP3 (0.69) NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214087-A1 COMBINATION TREATMENT WITH IL-1RA AND COMPOUNDS THAT INHIBIT IL-1 PROCESSING AND RELEASE Pfizer Products Inc. (US) 2002-06-19 EP disclosed
WO-2001019390-A1 COMBINATION TREATMENT WITH IL-1RA AND DIARYL SULPHONYL UREA COMPOUNDS PFIZER PRODUCTS INC. (US) 2001-03-22 WO disclosed